FFS
BBP icon

Founders Financial Securities’s Virtus Biotech ETF BBP Stock Holding History

Founders Financial Securities’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$216K Buy
+2,247
New +$196K 0.01% 522

Other funds holding BBP

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
ARC
Advisor Resource Council Dallas, Texas $355M AUM 30.05% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
IFWM
Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Founders Financial Securities's BBP Position: Q2 2026 in Review

Founders Financial Securities opened a new position in Virtus Biotech ETF (BBP) in Q2 2026: 2,247 shares worth $216K. The stake represents 0.01% of the portfolio and ranks #522 among its holdings.

9 funds tracked by Wall St. Rank hold BBP as of Q2 2026.

  • Founders Financial Securities held 2,247 shares of Virtus Biotech ETF worth $216K as of Q2 2026.
  • Virtus Biotech ETF was a new Founders Financial Securities position in Q2 2026.
  • Virtus Biotech ETF made up 0.01% of Founders Financial Securities's portfolio in Q2 2026, its #522 holding.
  • 9 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2026.

Based on Founders Financial Securities's 13F filing for Q2 2026, filed 31 Jul 2026.